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ABSTRACT 
Although a relationship between vascular disease and osteoporosis has been 
recognized, its clinical importance for fracture risk evaluation remains uncertain. 
Abdominal aortic calcification (AAC), a recognized measure of vascular disease 
detected on single-energy images performed for vertebral fracture assessment, may 
also identify increased osteoporosis risk. In a prospective 10-year study of 1,024 older 
predominantly Caucasian women (mean age 75.0±2.6 years) from the Perth 
Longitudinal Study of Aging cohort we evaluated the association between AAC, 
skeletal structure and fractures. AAC and spine fracture were assessed at the time of 
hip densitometry and heel quantitative ultrasound. AAC was scored 0 to 24 (AAC24) 
and categorized into; low AAC (score 0 and 1, n=459), moderate AAC (score 2-5, 
n=373) and severe AAC (score > 6, n=192). Prevalent vertebral fractures were 
calculated using the Genant semi-quantitative method. AAC24 scores were inversely 
related to hip bone mineral density (BMD) (rs=-0.077, p=0.013) and heel broadband 
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ultrasound attenuation (rs=-0.074, p=0.020) and stiffness index (rs=-0.073, p=0.022). 
In cross-sectional analyses women with moderate to severe AAC were more likely to 
have prevalent fracture and LSI detected lumbar spine but not thoracic spine fractures 
(Mantel-Haentzel test of trend p < 0.05). For 10-year incident clinical fractures and 
fracture-related hospitalizations women with moderate to severe AAC (AAC24 score 
>1) had increased fracture risk (HR 1.48 [1.15-1.91], p=0.002; HR 1.46 [1.07-1.99], 
p=0.019, respectively) compared to women with low AAC. This relationship 
remained significant after adjusting for age and hip BMD for clinical fractures (HR 
1.40 [1.08-1.81], p=0.010) but was attenuated for fracture-related hospitalizations 
(HR 1.33 [0.98-1.83], p=0.073). In conclusion, older women with more marked AAC 
are at higher risk of fracture, not completely captured by bone structural predictors. 
These findings further support the concept that vascular calcification and bone 
pathology may share similar mechanisms of causation that remain to be fully 
elucidated. 
KEY WORDS: Vascular calcification, Abdominal aortic calcification, Bone mineral 
density, heel quantitative ultrasound, Fractures.  
INTRODUCTION 
Vascular and bone diseases are considered to share common 
pathophysiological mechanisms. In particular arterial calcification processes have 
been shown to share some pathways in common with bone physiology.(1) At the 
clinical level osteoporosis and low bone mineral density (BMD) have been linked to a 
small increase in cardiovascular disease (CVD) risk in older populations potentially 
related to vascular calcification.(2) AAC is a marker of advanced atherosclerosis in 
other vascular beds including the thoracic aorta and iliac arteries,(3) carotid arteries 
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(4) and coronary arteries.(3,5) We and others have identified abdominal aortic 
calcification (AAC) as a marker of atherosclerotic vascular disease that may be 
involved in the association of bone and vascular disease.(6)  
It is important to understand that calcification of arterial tissue is not merely a 
passive process of calcium phosphate precipitation, but a highly organized process, 
regulated by mechanisms similar to those involved in bone mineralization.(7,8) 
Atherosclerotic lesions tend to originate around the major vessel bifurcations and the 
branching arteries. Branching arteries in the abdominal aorta supply blood and 
nutrients to the lumbar vertebrae. Therefore, occlusion of these arteries may result in 
ischemia in the lumbar spine, which can lead to degeneration and asymptomatic 
vertebral fractures.(9) Furthermore, local and systemic osteochondrogenic factors can 
be released by calcified atherosclerotic lesions, which can affect regional and 
systemic bone homeostasis. (10,11)  
In this paper we explore the hypothesis that the presence and severity of AAC 
is related to bone structure, prevalent fractures and incident fractures using the same 
population in which we previously identified an association between AAC and 
CVD.(6) To do this we used lateral spine imaging undertaken at the time of bone 
density testing.(12) 
METHODS 
This article complies with the STROBE reporting guidelines for observational 
studies. 
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Study Population  
In 1998, older women were recruited to a 5-year prospective, randomised, 
controlled trial of oral calcium supplements to prevent osteoporotic fractures, the 
Calcium Intake Fracture Outcome study (CAIFOS). This study continued as an 
epidemiological study, the Perth Longitudinal Study of Aging Women (PLSAW).(13) 
The trial was retrospectively registered in the Australian New Zealand Clinical Trials 
Registry (ACTRN12615000750583) as it was commenced and completed before the 
advent of the clinical trials registry. Participants were recruited from the Western 
Australian general population of women aged over 70 years by mail using the 
electoral roll, which is a requirement of citizenship. Of the 5,586 women approached, 
1,500 women were recruited into the study. All participants were ambulant with an 
expected survival beyond 5 years and were not receiving any medication (including 
hormone replacement therapy) known to affect bone metabolism. Baseline disease 
burden and medications were comparable between these participants and the general 
population of similar age.(13) In the subsequent 5 years following inclusion in the 
study, participants received 1.2 g of elemental calcium as calcium carbonate daily or a 
matching placebo. For the present study, women were included in the analysis if 
lateral spine images (collected in 1998 or 1999) and measurements of hip BMD were 
both available (n=1,024). The Human Ethics Committee of the University of Western 
Australia approved the study and written informed consents were obtained from all 
participants. Human ethics approval for the use of linked data for the project was 
provided by the Human Research Ethics Committee of the Western Australian 
Department of Health (DOHWA HREC), project number #2009/24.  
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Baseline risk assessment  
Participants provided their medical history and current medications verified by 
their General Practitioner. These data were coded using the International 
Classification of Primary Care – Plus (ICPC-Plus) method.(14) The coding 
methodology allows aggregation of different terms for similar pathologic entities as 
defined by the ICD-10 coding system. These data were then used to determine the 
presence of pre-existing diabetes (T89001-90009). Cardiovascular medications 
included anti-hypertensive medications, statins and low dose aspirin. Smoking status 
was coded as non-smoker or ex-smoker/current smoker if they had consumed more 
than 1 cigarette per day for more than 3 months at any time in their life. Weight was 
assessed using digital scales with participants wearing light clothes and no shoes. 
Height was assessed using a stadiometer and the body mass index was calculated in 
kg/m2 at baseline. Self-reported prevalent fractures were recorded if the fractures (i) 
occurred after the age of 50 years, (ii) were due to minimal trauma defined as falling 
from standing height or less, and (iii) not a fracture of the face, skull, or phalanges.  
Bone measurements 
Total hip bone mineral content (BMC) and density (BMD) was measured by 
Dual Energy X-ray Absorptiometry (DXA) using the Hologic Acclaim 4500A fan 
beam densitometer (Hologic Corp, Waltham, MA, USA) at baseline (1998) or year 
one (1999). The coefficients of variation (CV) at the total hip was 1.2% in our 
laboratory.(15) Quantitative heel ultrasound (QUS) of the calcaneus of the left foot 
was measured in duplicate using a Lunar Achilles Ultrasound machine (Lunar Corp., 
Madison, WI, USA) at baseline in 990 women. The average measurement of the 
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Speed of Sound (SOS), Broadband Ultrasound Attenuation (BUA) and Stiffness index 
(SI) were determined. The CV were 0.4% for SOS and 1.6% for BUA.  
Lateral spine imaging 
Digitally enhanced lateral single-energy images of the thoraco-lumbar spine 
were collected using the same Hologic 4500A machine (Hologic, Marlborough, MA, 
USA). A single experienced investigator (JTS), read all images and scored vertebral 
fractures using the Genant semi-quantitative method.(16) We included the 
modification that grade 1 fractures were considered fractures only if there was clear 
endplate depression or cortical discontinuity, as described in a prior publication.(17) 
The same investigator calculated all AAC scores from 0 to 24 using the established 
technique.(18-20) This investigator was blinded to all study participant characteristics 
and outcomes. Severity of AAC was categorized using previously published 
groupings for cardiovascular disease: low (AAC24 score 0 or 1), moderate (AAC24 
score 2-5) and severe (AAC24 score 6 or greater) AAC scores.(20) 
Biochemistry 
Fasting blood samples were collected at baseline (1998). Total cholesterol, 
high-density lipoprotein cholesterol (HDLC), serum calcium, serum phosphate and 
creatinine were measured. Creatinine was used to estimated glomerular filtration rate 
(eGFR). A detailed description of the methods related to the measurement of all 
circulating biological markers can be found in Supplementary Text 1. 
Clinical fractures & fracture hospitalizations 
The primary outcomes were incident clinical fracture and fracture 
hospitalizations. Incident clinical fractures were captured using an adverse events 
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diary collected every 4 months during the first 5 years and every 6 months during the 
subsequent 5 years of follow up (total of 10 years). From these self-reported fractures, 
low trauma clinical fractures resulting from falling from standing height or less, 
including minimally traumatic symptomatic vertebral fracture, were recorded (clinical 
fractures). All fractures were confirmed by radiographic records or General 
Practitioner reports. Hip and fracture-related hospitalizations over 10 years (1998-
2008) were identified using the Hospital Morbidity Dataset Collection, linked via the 
Western Australian Data Linkage System (WADLS). This system allows 
identification of admission to and discharge from all hospitals in Western Australia. 
Diagnosis codes were defined using the International Classification of Diseases, 
Injuries and Causes of Death: Clinical Modification (ICD-9-CM) codes 1998-1999 
(21) mapped to the International Statistical Classification of Diseases and Related 
Health Problems, 10th Revision, Australian Modification (ICD-10- AM) for 1999-
2013. (22) Codes used for identification were S02.0-S02.9, S12.0-S12.9, S22.0-S22.9, 
S32.0-S32.9, S42.0-S42.9, S52.0-S52.9, S62.0-S62.9, S72.0-S72.9, S82.0-S82.9, 
S92.0-S92.9, M80, T02, T08, T10, T12 and T14.2. Fractures of the face (S02.2-
S02.6), fingers (S62.5-S62.7), and toes (S92.4-S92.5) and fractures caused by motor 
vehicle injuries (External cause of injury codes V00-V99) were excluded.  
Estimated fracture risk 
The FRAX Australian major osteoporotic fracture risk prediction was 
determined using the calculator on the FRAX website (www.shef.ac.uk/FRAX). 
Baseline data were used to calculate the estimated 10-year risk of fracture using the 
FRAX Australian with and without BMD. Data used including: age, sex, weight (kg), 
height (cm), previous fracture, parental history of hip fracture, current smoking, 
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glucocorticoid use, history of rheumatoid arthritis or secondary osteoporosis and 
intake of 3 servings of alcohol per day. Data were input with and without femoral 
neck BMD (g/cm2). Secondary osteoporosis was an exclusion criteria for the initial 
randomized controlled trial and data on parental hip fracture was unavailable and was 
left blank meaning the answer to this question was assumed to be “no” for all women.  
Statistical analysis  
Baseline data are presented as either mean ± SD, median and IQR or number 
and (%) where appropriate. Chi squared tests or ANOVA to test the difference 
between severity of AAC (low AAC24 scores 0 or 1, moderate AAC24 scores 2-5 and 
severe AAC24 score ≥6) was applied where appropriate. Spearman’s rank correlation 
and age and treatment-adjusted partial correlation statistics were calculated for the 
correlation between AAC24 and hip BMD and heel ultrasound measures. Generalized 
additive model (GAM) was undertaken using the R package “mgcv”(23) to generate 
GAM graphic representations of the dose-response relations between AAC24 and the 
bone structural variables BMD and heel BUA, adjusted for age and treatment group, 
with method = REML and knots = NULL. Logistic regression was used to examine 
the relationship between AAC and prevalent fractures in unadjusted and age, 
treatment and total hip BMD-adjusted models. The primary outcomes were the hazard 
ratio (HR) for any incident clinical fracture or fracture hospitalization up until 10 
years. We performed analysis using three models: (Model 1) AAC unadjusted, 
(Model 2) model 1 + age and treatment (placebo vs. calcium or calcium with vitamin 
D2) adjusted and (Model 3) model 2 + total hip BMD adjusted analyses. For the 
primary Cox regression analyses, we treated deaths as censored. This approach means 
that the HRs can be interpreted as the risk of fracture for any time during follow-up 
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assuming that a woman stayed alive for that long. No violations of the Cox 
proportional hazards assumptions were detected. To investigate the non-linear 
relationship between AAC24 and incident fracture outcomes, hazard ratios (HRs) 
with 95% confidence intervals (CIs) were derived from Cox proportional hazard 
regression for each AAC24 point increase using AAC24=2 as the reference and 3 
knots. To investigate whether the association between AAC and incident fractures 
was modified by fracture risk factors or biomarkers we undertook interaction testing 
in age and treatment–adjusted models, with P<0.1 considered significant. Statistical 
analysis was performed using IBM SPSS Statistics for Windows, version 24.0 (IBM 
Corp., Armonk, NY, USA) and Stata software, version 14 (StataCorp LLC, College 
Station, Texas, USA). Statistical significance was set at a two-sided Type One error 
rate of p< 0.05 for all tests.  
RESULTS 
The participants mean (SD) age was 75.0 (2.6) years (n=1,024), with AAC 
present (AAC24 score > 0) in 72.9% of women. The median AAC score was 2 with 
an IQR of 0 and 4 (range = 0 to 18). Baseline characteristics of participants in the 
three AAC severity groups are presented in Table 1. Age was marginally higher in 
the moderate and severe AAC groups. Both of these groups had an increased 
proportion of previous or current smokers compare to the low AAC group but not 
prevalent diabetes 
AAC and cross-sectional measures of bone structure 
AAC24 scores and bone structure were inversely related before (hip BMD 
Spearman’s rank rho=-0.077, p=0.013), heel BUA (rho=-0.074, p=0.020) and 
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stiffness index (rho=-0.073, p=0.022) and after adjusting for age and treatment code 
(hip BMD r=-0.075, p=0.017, heel BUA r=-0.080, p=0.012 and stiffness index r=-
0.072, p=0.024). Women with severe AAC had a lower total hip BMD, heel BUA and 
stiffness index than those with low AAC in unadjusted analyses, with hip BMD and 
heel BUA remaining significant even after adjusting for age and treatment 
(Supplementary Figure 1). To investigate the “dose-response” relationship between 
AAC24 point scores and these bone measures further, we used age and treatment-
adjusted generalized additive model (Supplementary Figure 1). 
AAC and cross-sectional relationship with prevalent fractures (Table 1)  
Women with more severe AAC were more likely to have sustained one or 
more osteoporotic fractures since the age of 50 compared to those with low AAC in 
unadjusted analyses (OR 1.53 [1.05-2.24], p=0.026). However adjusting for age, 
treatment and total hip BMD, attenuated this relationship (OR 1.45 [1.00-2.11], 
p=0.051). Women with severe AAC were more likely to have a lumbar spine 
vertebral fractures seen on the lateral spine image in unadjusted (OR 1.74 [1.02-2.95, 
p=0.042, p=0.048). However, adjusting for age, treatment and total hip BMD, 
attenuated these relationships (OR 1.61 [0.94-2.74, p=0.084).  
AAC and 10-year incident fractures  
Over 8,135 person years of follow up, 253/1,024 (24.7%) women had 
experienced a clinical fracture while 169/1,024 (16.5%) were hospitalized for 
fractures (9,122 person years of follow-up). The Kaplan Meier curves for time to first 
clinically reported fracture or fracture-related hospitalization are shown in Figure 1. 
These data identified that the fracture risk was similar in participants with moderate 
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and severe AAC, thus these categories were combined for all subsequent analyses 
(Table 2). Compared to women with low AAC, women with moderate to severe AAC 
had increased risk of all clinical and clinical spine fractures and all hospitalized 
fractures, but not hip fractures. However, after further adjustment for total hip BMD, 
only clinical fracture, which included vertebral fractures remained significant (Table 
2). To explore the non-linear relationship between AAC24 and fracture, age and 
treatment restricted cubic splines were constructed (Supplementary Figure 2). A 
competing risk analysis including mortality as the competing risk obtained 
comparable results (Supplementary Table 1). Interaction testing identified a 
significant interaction (p=0.033) between AAC24 scores and prevalent VF, whereby 
the association of both moderate to severe AAC and prevalent vertebral fracture with 
incident clinical fracture was stronger in the presence of the other (Figure 2). 
However no interactions were observed for fracture hospitalizations or self-reported 
fractures since the age of 50 years. 
Potential clinical risk factors for incident fracture risk  
To assess the robustness of the findings, further analyses were performed 
adjusting for estimated fracture risk (FRAX) with and without BMD Supplementary 
Table 2. We also undertook extensive testing of individual clinical effect modifiers to 
identify whether the association between AAC and incident fractures were different in 
women with different clinical fracture and cardiovascular risk factors (Table 3). This 
analysis identified HDLC as a potential effect modifier whereby the strongest 
association between AAC and fractures was seen in people with higher levels of HDL 
cholesterol. We did not identify any other clinical risk factors modifying the 
relationship between AAC and fracture risk. 
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DISCUSSION 
We confirmed previous associations between increased severity of AAC with 
low total hip BMD, and increased prevalent fractures and LSI detected lumbar 
vertebral fractures. We also demonstrated that AAC was related to heel quantitative 
ultrasound measures of bone quality. Furthermore for prospective fracture outcomes, 
both moderate to severe AAC was associated with increased risk of clinical and 
serious fractures requiring hospitalization. Importantly, we observed similar 
associations with both self-reported verified clinical fractures as well as fracture 
hospitalisations that are independent of self-report increasing the confidence in the 
findings. The associations also remained similar when undertaking competing risk 
analysis, suggesting survival bias does not explain the relationship between AAC and 
fracture.  
The findings that severe AAC are associated with lower hip bone mineral 
density are in accord with those of Bagger et. al. (24), who found in a large cohort of 
postmenopausal women (n=2,662, mean age= 65 years) that women with AAC24 
scores ≥3 had lower hip and spine BMD, independent of age and BMI. Similarly, 
Szulc et al found in a cohort of men (n=781, age≥ 50 years) that individuals with 
severe AAC (AAC24 scores >6) had significantly lower BMD at a number of sites 
than those with AAC24 scores ≤6 over 10 years. (25) However, two cross-sectional 
studies of older women reported that the association between AAC and BMD were 
non-significant after adjusting for age.(26,27) However these studies only assessed 
the association between the presence of any AAC and BMD, without accounting for 
the severity. Additionally, our study also investigated and demonstrated severe AAC 
was associated with lower heel BUA. Collectively, the present literature suggests that 
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more advanced AAC is associated with lower BMD of the skeleton at multiple sites 
by an as yet unknown mechanism.  
Regarding mechanism(s) in this study, a possible explanation is that AAC 
impairs vascular supply of oxygenated blood and nutrients to the skeleton at both the 
hip and heel bone. Additionally, as the abdominal aorta supplies oxygenated blood to 
the intestines via the mesenteric arteries, reduced vascular supply may also lead to 
malabsorption of essential nutrients and vitamins. Another potential mechanism is 
circulating factors from the “injured” calcified vasculature affecting BMD at multiple 
skeletal sites such as the observed relationship to the hip and heel bones. 
Alternatively, there are well known shared genetic and environmental risk factors for 
both the skeleton and the vasculature.(28)  
Regarding the association of baseline AAC and with self-reported fractures 
from the age of 50 years and the number and severity of prevalent vertebral fractures 
of the lumbar spine. The data confirm and expand upon previous cross-sectional 
studies investigating the association between AAC and prevalent fracture, including 
the cross-sectional study of older men and women by Naves et al. (29) and the cross-
sectional study of the STRAMBO cohort of older men by Szulc et al. with prevalent 
vertebral fractures.(30)  
To our knowledge this is the first study to have investigated the association of 
severe AAC reporting the vertebral fractures of the thoracic and lumbar regions 
separately. The association between AAC and incident fractures was most 
pronounced for clinical spine fracture that are often associated with substantial pain, 
morbidity, and loss of mobility that is comparable to hip fractures.(31-34) Given that 
the L1-L4 lumbar arteries arise from the abdominal aorta severe atherosclerosis and 
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stenosis of these arteries and/or production of anti-calcific molecules by the injured 
vasculature may lead to more rapid regional bone loss and failure of the vertebral 
structure. These findings support previous prospective studies of older men and 
Chinese women that have reported the association between AAC and any vertebral 
fractures. (25,35,36)  
Regarding incident fracture risk moderate to severe AAC was associated with 
increased clinical spine and clinical fractures, independent of age, treatment and 
BMD, while the association was attenuated for fracture-related hospitalizations and 
was non-significant for the few hip fractures that occurred. Importantly, while the 
absolute risk difference was relatively modest 5.4-7.6% over 10-years, this increased 
fracture risk was observed in 55% women (those with moderate to severe AAC) 
indicating that AAC may be an important fracture risk factor in older Caucasian 
women. Furthermore, AAC was associated with fracture independent of conventional 
fracture risk factors suggesting a novel potentially non-BMD mechanism. A previous 
nested case-cohort study in older women (n=951, mean age~ 72 years) found that an 
AAC24 score >4 assessed from DXA-derived lateral spine images was not associated 
with risk of non-vertebral fractures after 4 or 15-years, but was associated with higher 
4-year risk of vertebral fractures and 5-year risk of hip fractures.(37) A prospective 
study of older men (n=5400, aged ≥65 years), found severe AAC was associated with 
a high risk of hip fracture but not non-hip fractures.(36) These discordant differences 
between the current study and the abovementioned studies may have been due to the 
cut-point selected, fracture ascertainment methods or population differences.  
Another potential explanation is differences in the metabolic health of the 
cohorts, potentially modifying the relationship between AAC and incident fractures. 
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An interaction between AAC with HDLC for fracture outcomes was observed. 
Specifically, the relationship between AAC, clinical fractures and fracture 
hospitalizations was stronger in women with higher levels of HDLC that are typically 
associated with better metabolic health and reduced cardiovascular risk. HDLC is a 
recognised marker of reduced coronary heart disease and is anti-atherogenic via its 
anti-inflammatory and antioxidant properties.(38) These findings suggest that 
metabolic dysfunction associated with ageing may mask the true strength of the 
relationship between AAC and fractures. However, these findings should be 
interpreted with caution, as they are based on hypothesis generating analysis and need 
to be replicated in other cohorts of older women.  
Women with both prevalent vertebral fractures and moderate to severe AAC 
had substantially higher incident fracture risk than either conditional alone. These 
findings suggest that concurrently capturing both prevalent vertebral fractures and 
AAC may identify a small (5.3%) but previously underappreciated high risk subset of 
women where fracture is remarkably common (10-year any fracture 45% and fracture 
hospitalization 24%).  
There are a number of important limitations of our study that must be 
considered. Firstly, this was an observational study and as such causation cannot be 
established. Secondly, we cannot exclude the possibility of bias being introduced, 
particularly as the lateral spine images were only assessed in ~70% of the larger 
cohort. Furthermore, biomarkers were only available in a subgroup of women. 
Thirdly, the AAC24 point scale scoring system is only semi-quantitative and 
dependent on the reader’s expertise. Nonetheless, a highly experienced investigator 
(J.T.S) read all images in this study. Fourthly, AAC was only assessed once at 
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baseline (between 1998 to 1999). Therefore, we cannot deduce the temporality of the 
association. Fifthly, we did not measure some established biomarkers of inflammation 
such as hs-CRP or TNF-alpha. Finally, as this cohort consisted predominantly of 
elderly Caucasian women with an average age of 75 years, these may not be 
generalizable to younger women, or men, or older women of other ethnicities.  
Despite these limitations, the strengths of this study include the size of the 
cohort of older women that has similar disease burden and medication use to the 
population typically undergoing bone densitometry for osteoporosis screening. 
Additional strengths include, long-term prospective follow-up (10 years), capturing 
fracture events through both, verified self-report (by GP), as well as fracture-related 
hospitalizations and deaths from the Western Australian Data Linkage System 
independent of self-report. Furthermore, a single highly experienced investigator 
(J.T.S) assessed all lateral spine images in this study. Finally, we investigated the 
potential effect modifiers of the association capturing a range of disease processes 
such as metabolic dysfunction, renal function as well as circulating bone and vascular 
calcification biomarkers. 
In conclusion, we have confirmed previous findings that increasing AAC is 
associated with increased prevalence of vertebral fractures, reduced hip BMD and 
have extended these findings to heel quantitative ultrasound measures. We also 
demonstrated robust associations between AAC and 10-year vertebral and non-
vertebral clinical fractures, independent of clinical fracture risk factors. These 
findings add further support to the concept that vascular calcification and bone 
pathology may share similar mechanisms that remain to be fully elucidated. Finally 
women with both prevalent vertebral fractures and moderate to severe AAC had 
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substantially higher incident fracture risk than either conditional alone. These findings 
suggest that concurrently capturing prevalent vertebral fractures and AAC may 
identify a small but previously underappreciated group of women at high risk of 
future fracture.  
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Table 1. Baseline characteristics and bone related variables stratified by abdominal aortic 
calcification (AAC) severity. 
Demographics All  
Low AAC Moderate AAC Severe AAC 
(AAC24 score 
0 or 1) 
(AAC24 
score 2-5) 
(AAC24 
score ≥6) 
Number 1,024 459 (44.8) 373 (36.4) 192 (18.7) 
Age, years 75.0 ± 2.6 74.8 ± 2.6 74.9 ± 2.5 75.4 ± 2.7 
Heigth, cm 159.1 ± 5.7 159.2 ± 5.6 159.4 ± 5.9 158.0 ± 5.6 
Weight, kg 68.5 ± 11.8 69.2 ± 12.3 69.4 ± 12.2 65.2 ± 9.3 
More than 3 standard alcoholic 
drinks/day, yes (%) 35 (3.4) 14 (3.1) 13 (3.5) 8 (4.2) 
Randomization     
 Placebo, yes (%) 511 (49.9) 236 (46.2) 175 (34.2) 100 (19.6) 
 Calcium, yes (%) 485 (47.4) 212 (43.7) 186 (38.4) 87 (17.9) 
 Calcium plus vit D2, yes (%) 28 (2.7) 11 (39.3) 12 (42.9) 5 (17.9) 
Smoker ever, yes (%) 368 (35.9) 131 (28.5) 155 (41.6) 82 (42.7) 
Diabetes, yes (%) 57 (5.6) 22 (4.8) 24 (6.4) 11 (5.7) 
Hip data     
 Total hip area, cm 35.2 ± 3.2 35.3 ± 3.3 35.4 ± 3.1 34.8 ± 3.2 
 Total hip BMC, g 28.7 ± 5.3 29.1 ± 5.5 28.7 ± 5.2 27.5 ± 5.2 
 Total hip BMD, mg/cm2 0.81 ± 0.12 0.82 ± 0.13 0.81 ± 0.12 0.79 ± 0.12 
FRAX (Aust) with FN BMD 8.0 ± 3.8 7.6 ± 3.4 8.0 ± 3.9 8.9 ± 4.0 
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Heel (calcaneal) bone data     
 Heel broadband ultrasound 
attenuation, db/Mhz* 100.6 ± 7.9 101.2 ± 7.8 100.7 ± 7.9 99.1 ± 8.0 
 Heel speed of sound, m/s* 1513 ± 25 1515.0 ± 25.7 1512.6 ± 24.7 
1511.3 ± 
25.1 
 Heel stiffness index, %* 70.8 ± 11.3 71.6 ± 11.4 70.8 ± 11.1 69.1 ± 11.2 
Prevalent fracture from age 50 years     
 Any fracture, yes (%)  264 (25.8) 103 (22.4) 102 (27.3) 59 (30.7) 
Prevalent vertebral fracture from 
VFA 
    
 None, yes (%) 930 (90.9) 421 (91.7) 343 (92.2) 166 (86.5) 
 One, yes (%) 75 (7.3) 33 (7.2) 22 (5.9) 20 (10.4) 
 Two or more, yes (%) 18 (1.8) 5 (1.1) 7 (1.9) 6 (3.1) 
 Grade of vertebral fractures      
 None, yes (%) 930 (90.9) 421 (91.7) 343 (92.2) 166 (86.5) 
 Grade 1 only, yes (%) 35 (3.4) 17 (3.7) 11 (3.0) 7 (3.6) 
 Grade two or three, yes (%) 58 (5.7) 21 (4.6) 18 (4.8) 19 (9.9) 
Location of vertebral fracture from 
VFA 
    
 Thoracic VF, yes (%) 72 (7.0) 28 (6.1) 26 (7.0) 18 (9.4) 
 Lumbar VF, yes (%)#  24 (2.3) 10 (2.2) 4 (1.1) 10 (5.2) 
 This article is protected by copyright. All rights reserved. 
A
cc
ep
te
d 
A
rt
ic
le
  
Table 2. Hazard ratios (HR) for 10-year fracture risk by abdominal aortic calcification (AAC) 
category. 
 Number 
of women 
with 
fracture 
(%) 
Age & 
treatment-
adjusted 
HR 
(95%CI) 
p 
value 
Age, treatment 
& hip BMD -
adjusted HR 
(95% CI) 
p 
value 
Clinical fracture*      
 Low AAC 94/459 
(20.5) 
1 
(reference) 
 1 (reference)  
 Moderate to severe AAC 159/565 
(28.1) 
1.47 (1.14-
1.90) 
0.003 1.40 (1.08-1.81) 0.010 
Clinical vertebral fracture      
 Low AAC 20/459 
(4.4) 
1 
(reference) 
 1 (reference)  
 Moderate to severe AAC 48/565 
(8.5) 
1.98 (1.18-
3.34) 
0.010 1.84 (1.09-3.10) 0.023 
Clinical non-vertebral 
fracture 
     
 Low AAC 80/459 
(17.4) 
1 
(reference) 
 1 (reference)  
 Moderate to severe AAC 130/565 
(23.0) 
1.38 (1.04-
1.82) 
0.024 1.32 (1.00-1.75) 0.051 
Data expressed as mean ± SD or number and (%). AAC abdominal aortic calcification; 
BMD bone mineral density; BMC bone mineral content; FRAX Fracture risk assessment 
tool; VF vertebral fracture; Rows in bold represent significant differences (p-value<0.05) 
across AAC categories tested by ANOVA or Mantel-Haentzel test of trend where 
appropriate. *Measured in 990 participants at baseline. # Some patients had both thoracic 
and lumbar spine fractures.  
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Fracture hospitalization       
 Low AAC 62/459 
(13.5) 
1 
(reference) 
 1 (reference)  
 Moderate to severe AAC 107/565 
(18.9) 
1.42 (1.04-
1.94) 
0.028 1.33 (0.98-1.83) 0.073 
Hip fracture 
hospitalization 
     
 Low AAC 22/459 
(4.8) 
1 
(reference) 
 1 (reference)  
 Moderate to severe AAC 39/565 
(6.9) 
1.43 (0.85-
2.41) 
0.186 1.31 (0.77-2.22) 0.315 
AAC abdominal aortic calcification; BMD bone mineral density. *Clinical vertebral and non-
vertebral fracture numbers do not equal total clinical fracture numbers as women may have 
suffered more than 1 fracture type. Rows in bold represent significant differences. 
 
Table 3. Age and treatment-adjusted relative hazards for 10-year fracture in women with moderate-
severe AAC vs. low AAC by potential clinical effect modifiers. 
 
Subset according to baseline 
characteristic 
Clinical fracture 
(n = 263) 
Fracture hospitalization  
(n = 169) 
 HR 
(95%CI) 
p-value 
inter. 
HR 
(95%CI) 
p-value 
inter. 
Age (years)     
 <75 years, (n=501) 1.59 (1.08-2.33) 0.858 1.40 (0.84-2.32) 0.815 
 ≥75, (n=523) 1.39 (0.99-1.96)  1.46 (0.98-2.17)  
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Smoking history     
 No, (n=653) 1.37 (0.99-1.90) 0.724 1.55 (1.04-2.33) 0.338 
 Yes, (n=368) 1.50 (0.98-2.30)  1.20 (0.72-1.99)  
Treatment code     
 Placebo, (n=511) 1.33 (0.94-1.86)  1.44 (0.92-2.27)  
 Calcium, (n=485) 1.77 (1.18-2.65) 0.500 1.42 (0.90-2.23) 0.860 
 Calcium plus D2 (n=28) 0.47 (0.08-2.63)  0.89 (0.14-5.70)  
History of ASVD     
 No, (n=912) 1.43 (1.09-1.87) 0.566 1.45 (1.04-2.03) 0.609 
 Yes, (n=112) 1.87 (0.80-4.34)  1.04 (0.42-2.55)  
eGFR, n=923     
 ≥60 ml/min/1.73m2, (n=636) 1.37 (0.99-1.90) 0.897 1.71 (1.13-2.59) 0.124 
 <60 ml/min/1.73m2, (n=287) 1.43 (0.87-2.32)  1.00 (0.57-1.76)  
Serum phosphate n=923     
 Tertile 1, (n=294) 1.34 (0.81-2.22)  1.38 (0.76-2.50)  
 Tertile 2, (n=303) 1.45 (0.90-2.34) 0.593 2.05 (1.08-3.88) 0.456 
 Tertile 3, (n=326) 1.40 (0.91-2.16)  1.11 (0.66-1.88)  
Serum calcium, n=923     
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 Tertile 1, (n=307) 1.61 (1.01-2.58)  1.54 (0.87-2.75)  
 Tertile 2, (n=269) 1.32 (0.80-2.18) 0.433 1.14 (0.62-2.12) 0.982 
 Tertile 3, (n=347) 1.21 (0.77-1.89)  1.48 (0.85-2.58)  
History of diabetes     
 No, (n=967) 1.52 (1.17-1.99) 0.211 1.45 (1.04-2.02) 0.434 
 Yes, (n=57) 0.84 (0.35-2.01)  1.02 (0.39-2.67)  
Systolic blood pressure    
 <140 mmHg, (n=522) 1.78 (1.26-2.52) 0.120 1.54 (0.99-2.40) 0.948 
 ≥140 mmHg, (n=473) 1.14 (0.77-1.70)  1.28 (0.80-2.03)  
Antihypertensive medications    
 No, (n=589) 1.41 (1.02-1.96) 0.576 1.34 (0.89-2.00) 0.646 
 Yes, (n=435) 1.67 (1.10-2.55)  1.59 (0.95-2.65)  
Lipid lowering therapy     
 No, (n=830) 1.50 (1.13-1.99) 0.754 1.47 (1.04-2.09) 0.465 
 Yes, (n=194) 1.38 (0.73-2.61)  1.11 (0.55-2.26)  
Body mass index      
 <25 kg/m2, (n=351) 1.69 (1.10-2.59)  1.37 (0.82-2.28)  
 ≥25-29 kg/m2, (n=450) 1.28 (0.86-1.93) 0.266 1.28 (0.78-2.10) 0.753 
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 ≥30 kg/m2, (n=223) 1.57 (0.92-2.66)  1.71 (0.86-3.38)  
HDLC, n=829     
 <1.3 mmol, (n=293) 0.90 (0.54-1.48) 0.071 0.69 (0.36-1.32) 0.007 
 ≥1.3 mmol, (n=536) 1.55 (1.11-2.18)  2.00 (1.28-3.11)  
Total cholesterol, n=829     
 <5.3mmol, (n=610) 1.41 (1.02-1.95) 0.282 1.62 (1.06-2.50) 0.125 
 ≥5.3 mmol, (n=219) 1.00 (0.59-1.71)  0.90 (0.48-1.72)  
AAC abdominal aortic calcification; ASVD atherosclerotic vascular disease. Hazard ratio (HR) for 
fracture compares the low vs. moderate to severe categories of AAC. 
p-value inter. represents the p-value for the interaction (p<0.1) between severity of AAC (low vs. 
moderate to severe) with the listed variables as a continuous or binary variable where appropriate. 
Bolded values represent significant differences. 
 
 
 
 
 
 
 
 
 
 
 
FIGURE LEGENDS 
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Figure 1. Kaplan Meier survival curves for 10-year a) clinical fractures and b) 
fractures requiring hospitalization by severity of AAC (black line=low AAC, dark 
grey line=moderate AAC and light grey line=severe AAC). Vertical lines represent 
censored cases.  
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Figure 2. Multivariable-adjusted Cox proportional hazards regression for 10-year 
clinical fractures in (a) age and treatment-adjusted; (b) age, treatment and total hip 
BMD-adjusted models by moderate to severe AAC and presence or absence of 
prevalent vertebral fractures. Blue line = low AAC and no vertebral fracture [n=421], 
beige line = low AAC with vertebral fracture [n=38], green line = moderate to severe 
AAC and no vertebral fracture [n=510] and purple line = moderate to severe AAC 
with vertebral fracture [n=55]. 
 
 
